- Conditions
- B-Cell Prolymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +51 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Clinical trial condition
Leukemia, Prolymphocytic, T-Cell
Explore clinical trials studying Leukemia, Prolymphocytic, T-Cell. Study availability and eligibility vary by location and protocol.
25 public trials
9 recruiting studies
Leukemia, Prolymphocytic, T-Cell trial results
NCT00060424
- Conditions
- B-Cell Prolymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
- Locations
-
- Veterans Administration Center-Seattle Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
Completed
Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
NCT00124189
- Conditions
- Chronic Disease, Chronic Lymphoproliferative Diseases, Disease Attributes, +17 more
- Locations
-
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Roswell Park Cancer Center Buffalo, New York, United States
- Long Island Jewish Medical Center New Hyde Park, New York, United States
NCT00749502
- Conditions
- Adnexal Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +38 more
- Locations
-
Not specified
Active, Not Recruiting
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
NCT05823571
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, CML, +34 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States